Tumor-specific cytolysis by lymphocytes infiltrating human melanomas
- PMID: 2785562
Tumor-specific cytolysis by lymphocytes infiltrating human melanomas
Abstract
Tumor infiltrating lymphocytes (TIL) were grown in IL-2 from single cell tumor suspensions of 14 human melanomas resected from 12 patients. As a function of time in culture, 4 of 14 TIL cultures eventually expressed highly specific cytolytic activity against fresh autologous melanoma targets in short term chromium release assays, failing to lyse multiple allogeneic tumors or autologous normal cells. These highly specific TIL were identified as CTL by phenotype (CD3+/CD4-/CD8+/Leu7-) and by function (lysis inhibited by antibodies directed against CD3 and MHC class I molecules). Cell separation experiments using immunomagnetic beads identified a highly tumor-specific CTL subpopulation within a nonspecific TIL culture, suggesting that the lytic activity of tumor-specific CTL may be diluted by the nonspecific killer activity present in heterogeneous TIL cultures. These studies provide evidence for specific MHC-restricted human immune responses against autologous tumor in cancer-bearing patients, and may be of importance to ongoing clinical trials using TIL in the immunotherapy of advanced malignancies.
Similar articles
-
Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.J Immunol. 1989 Nov 15;143(10):3404-11. J Immunol. 1989. PMID: 2509557
-
Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.J Immunol. 1988 Jun 1;140(11):4042-9. J Immunol. 1988. PMID: 3286766
-
Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.J Immunother (1991). 1991 Jun;10(3):153-64. J Immunother (1991). 1991. PMID: 1868040
-
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.Cancer Res. 1986 Jun;46(6):3011-7. Cancer Res. 1986. PMID: 3486040
-
Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures.J Immunol. 1990 Jun 1;144(11):4487-95. J Immunol. 1990. PMID: 2160503
Cited by
-
Augmentation of interleukin-2-induced activation of human melanoma tumor-infiltrating lymphocytes by heteroconjugate antibody.Cancer Immunol Immunother. 1991;33(4):247-54. doi: 10.1007/BF01744944. Cancer Immunol Immunother. 1991. PMID: 1829394 Free PMC article.
-
Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report.Oncol Lett. 2018 Dec;16(6):6998-7007. doi: 10.3892/ol.2018.9534. Epub 2018 Oct 1. Oncol Lett. 2018. PMID: 30546433 Free PMC article.
-
Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA.J Immunol. 1993 Aug 1;151(3):1410-8. J Immunol. 1993. PMID: 8335937 Free PMC article.
-
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.Cancer Immunol Immunother. 2011 May;60(5):739-49. doi: 10.1007/s00262-011-0977-7. Epub 2011 Feb 9. Cancer Immunol Immunother. 2011. PMID: 21305379 Free PMC article.
-
Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.J Clin Invest. 1993 Mar;91(3):1183-90. doi: 10.1172/JCI116278. J Clin Invest. 1993. PMID: 8450047 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials